metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Evaluation of the early response to empirical treatment and its association with...
Journal Information
Vol. 27. Issue S3.
Abstracts from XVII Mexican Congress of Hepatology
(December 2022)
Share
Share
Download PDF
More article options
Vol. 27. Issue S3.
Abstracts from XVII Mexican Congress of Hepatology
(December 2022)
Open Access
Evaluation of the early response to empirical treatment and its association with cultures in patients with spontaneous bacterial peritonitis (SBP)
Visits
233
ST Carrión, F Garcia-Juarez, P Diego-Salazar, E Medina-Ávalos, M Carmona-Castillo, C Dorantes-Nava, F Higuera-de la Tijera, JL Pérez-Hernández
General Hospital of México “Dr. Eduardo Liceaga.” Mexico City, Mexico
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Download PDF
Statistics
Figures (1)
Special issue
This article is part of special issue:
Vol. 27. Issue S3

Abstracts from XVII Mexican Congress of Hepatology

More info
Introduction and Objectives

Spontaneous bacterial peritonitis (SBP) is a frequent complication in cirrhotic patients; the start of treatment is empirical and is adjusted with cultures. The antibiotic of choice is cephalosporins, which have reported high resistance. Improving SBP conditions has an impact on the evolution of patients. This study aimed to assess the early treatment response of SBP treated with empiric antibiotics.

Patients and Methods

Patients with a diagnosis of cirrhosis and SBP were included who underwent diagnostic paracentesis and paracentesis thee days after starting treatment; a decrease in ascites cellularity was evaluated as a criterion of response to treatment and the culture report. Descriptive and inferential statistics were performed. The trial was approved by the research ethics committee, and informed consent was obtained.

Results

Six hundred twenty-one patients diagnosed with liver cirrhosis were included. Forty-seven met the criteria for SBP. Thirty men (63%) and 17 women (36%); the causes of cirrhosis were: Alcohol 25 (53%), MAFLD 9 (19%), autoimmune 2 (4%) and unknown 10 (21%) By Child-Pugh B 12 (25%) and 35 (74%) C. 89% (42) received cephalosporins, of which 78% (33) responded to treatment (figure 1), of which 66% (23) did not isolated agent in culture, only 31% (10) developed bacterial agent, mainly E. coli (60%).

Conclusions

SBP is the most common cause of infections in cirrhotic patients, with a high impact on morbidity and mortality. Despite reports of resistance to cephalosporins in our population, the response to empirical treatment with cephalosporins is still optimal.

Funding

The resources used in this study were from the hospital without any additional financing

Declaration of interest

The authors declare no potential conflicts of interest.

Full Text

Figure 1: Comparative table of neutrophils on day zero and day three of treatment.

Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aohep.2022.100800
No mostrar más